Chong Yan

机构：Hohai University · ORCID：0009-0009-1451-3388

发表论文 91 篇 · 总被引 1479 次 · h-index 23

代表论文

• Batoclimab vs Placebo for Generalized Myasthenia Gravis (2024 · JAMA Neurology · 被引 48)
• Efgartigimod for generalized myasthenia gravis: A multicenter real‐world cohort study in China (2024 · Annals of Clinical and Translational Neurology · 被引 45)
• Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case series (2024 · Frontiers in Immunology · 被引 32)
• Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypes (2025 · Therapeutic Advances in Neurological Disorders · 被引 23)
• Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort study (2024 · Therapeutic Advances in Neurological Disorders · 被引 17)
• Independent risk factors for in-hospital outcome of myasthenic crisis: a prospective cohort study (2024 · Therapeutic Advances in Neurological Disorders · 被引 13)